TREATMENT OF CHRONIC CONGESTIVE HEART FAILURE WITH NEOHYDRIN FOR FROM EIGHT TO 65 MONTHS

Publisher Website
Google Scholar
Abstract
Twenty-three patients, more than half of whom were over age 60, who were in chronic congestive heart failure, were treated with 3-chloromercuri-2-methoxy-propylurea (Neohydrin) for a period of time varying from 8 to 65 months, with satisfactory results. Patients without primary renal disease, but with albuminuria and high nonprotein nitrogen due to congestive circulatory changes, can be adequately and safely treated with Neohydrin for long periods of time.